Literature DB >> 24660602

Efficacy of Chinese herbal medicine for lumbar disc herniation: a systematic review of randomized controlled trials.

Yi Luo, Jian Huang, Lin Xu, Weikang Zhao, Jie Hao, Zhenming Hu.   

Abstract

OBJECTIVE: This is a review of the effects of Chinese herbal medicine (CHM) used alone to treat lumbar disc herniation (LDH).
METHODS: A literature search of the following electronic databases from their inception to February 2013 was conducted: Chinese Biomedical databases, Chinese National Knowledge Infrastructure, Wanfang Database, China Science and Technology Journal Database, Cochrane Library, Web of Science, MEDLINE, and EMBASE. Randomized controlled trials where CHM had been used to treat LDH were selected. Data extraction, quality assessment, and data analysis were carried out by two independent reviewers.
RESULTS: Of the 2415 studies identified, eight with complete data on 1146 patients were selected. The methodological quality was poor in all trials. Five studies reported that CHM was better than Western Medicine [OR = 2.81, 95% CI (1.27, 6.18); OR = 3.34, 95% CI (1.92, 5.79); OR = 2.22, 95% CI (1.08, 4.57); OR = 6.67, 95% CI (1.34, 33.28); and OR = 1.94, 95% CI (1.23, 3.06)]. Two studies reported that the clinical outcome was better in CHM groups than in physiotherapy and placebo groups, [OR = 3.02, 95% CI (1.08, 8.46); and OR = 2.67, 95% CI (1.26, 5.64), respectively], whereas one study reported no difference between CHM and physiotherapy groups. One study reported that CHM resulted in higher Japanese Orthopedic Association scores [MD = 7.78, 95% CI (6.67, 8.89)] than in a control group and another that participants treated with CHM had lower Visual Analogue Scale scores [MD = -0.72, 95% CI (- 0.86, -0.58)] than those in a control group. Three studies reported that the adverse effects of CHM and Western Medicine did not differ significantly [OR = 0.10, 95% Cl (0.01, 1.85); OR = 0.19, 95% CI (0.01, 4.07); and OR = 0.07, 95% CI (0.00, 1.32)].
CONCLUSION: CHM may be more effective than other interventions for LDH; however, methodological weaknesses in the studies assessed in this review prevent a definitive conclusion. More high-quality large-scale studies are required to clarify this matter.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24660602     DOI: 10.1016/s0254-6272(14)60003-0

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

1.  Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial.

Authors:  Bonhyuk Goo; Sung-Jin Kim; Eun-Jung Kim; Dongwoo Nam; Hyun-Jong Lee; Jae-Soo Kim; Yeon-Cheol Park; Yong-Hyeon Baek; Sang-Soo Nam; Byung-Kwan Seo
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

2.  Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study.

Authors:  Feng Dai; Yu Xiang Dai; Hong Jiang; Peng Fei Yu; Jin Tao Liu
Journal:  BMC Musculoskelet Disord       Date:  2020-10-19       Impact factor: 2.362

3.  Traditional Chinese medicine in collaboration with conservative conventional medicine for lumbar herniated intervertebral disc: A protocol for systematic review and meta-analysis.

Authors:  Hyungsuk Kim; Won-Seok Chung
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

4.  Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration.

Authors:  Huihao Zhang; Sai Yao; Zhiguo Zhang; Chengcong Zhou; Fangda Fu; Yishan Bian; Huan Luo; Yan Li; Shuxin Yan; Yuying Ge; Yuying Chen; Kunyu Zhan; Yanzhi Ge; Zuxiang Chen; Ming Yue; Xiaofeng Li; Weibin Du; Hongting Jin; Peijian Tong; Hongfeng Ruan; Chengliang Wu
Journal:  Drug Des Devel Ther       Date:  2021-12-02       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.